S Eguchi1, S Miyashita, Y Kitamura, H Kawasaki. 1. Department of Clinical Pharmaceutical Science, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan.
Abstract
BACKGROUND AND PURPOSE: Previous studies demonstrated that nicotine-induced endothelium-independent vasodilation is mediated by perivascular adrenergic nerves and nerves releasing calcitonin gene-related peptide (CGRPergic nerves). We characterized the nicotinic acetylcholine (ACh) receptor subtype underlying the vasodilation in response to nicotine in rat mesenteric arteries. EXPERIMENTAL APPROACH: Rat mesenteric vascular beds without endothelium were contracted by perfusion with Krebs solution containing methoxamine and the perfusion pressure was measured with a pressure transducer. KEY RESULTS: Perfusion of nicotine (1-100 microM) for 1 min caused a concentration-dependent decrease in perfusion pressure due to vasodilation. Perfusion of (+/-)-epibatidine (1-100 nM) (non-selective agonist) or (-)-cytisine (1-100 microM) (partial agonist for nicotinic beta2 subtype and full agonist for nicotinic beta4 subtype) induced vasodilation in a concentration-dependent manner. Vasodilation induced by nicotine, (-)-cytisine- and (+/-)-epibatidine was markedly attenuated by guanethidine (5 microM) and pretreatment with capsaicin (1 microM). Mecamylamine (relatively selective antagonist for alpha3beta4 subtype), but not dihydro-beta-erythroidine (selective antagonist for alpha4beta2 subtype) or alpha-bungarotoxin (selective antagonist for alpha7 subtype), markedly inhibited nicotine-induced vasodilation. Nicotine-induced vasodilation was inhibited by methyllycaconitine at high concentrations (>1 microM), which non-selectively antagonize nicotinic receptors, while a low concentration of 10 nM, which selectively antagonizes alpha7 subtype, had no effect. (-)-Cytisine and (+/-)-epibatidine-induced vasodilation were abolished by mecamylamine. CONCLUSION AND IMPLICATIONS: These results suggest that the nicotinic alpha3beta4 receptor subtype, but not the alpha7 and alpha4beta2 subtypes, is responsible for the vasodilation in rat mesenteric arteries induced by nicotine- and nicotinic ACh receptor agonists through stimulation of adrenergic and CGRPergic perivascular nerves.
BACKGROUND AND PURPOSE: Previous studies demonstrated that nicotine-induced endothelium-independent vasodilation is mediated by perivascular adrenergic nerves and nerves releasing calcitonin gene-related peptide (CGRPergic nerves). We characterized the nicotinic acetylcholine (ACh) receptor subtype underlying the vasodilation in response to nicotine in rat mesenteric arteries. EXPERIMENTAL APPROACH: Rat mesenteric vascular beds without endothelium were contracted by perfusion with Krebs solution containing methoxamine and the perfusion pressure was measured with a pressure transducer. KEY RESULTS: Perfusion of nicotine (1-100 microM) for 1 min caused a concentration-dependent decrease in perfusion pressure due to vasodilation. Perfusion of (+/-)-epibatidine (1-100 nM) (non-selective agonist) or (-)-cytisine (1-100 microM) (partial agonist for nicotinic beta2 subtype and full agonist for nicotinic beta4 subtype) induced vasodilation in a concentration-dependent manner. Vasodilation induced by nicotine, (-)-cytisine- and (+/-)-epibatidine was markedly attenuated by guanethidine (5 microM) and pretreatment with capsaicin (1 microM). Mecamylamine (relatively selective antagonist for alpha3beta4 subtype), but not dihydro-beta-erythroidine (selective antagonist for alpha4beta2 subtype) or alpha-bungarotoxin (selective antagonist for alpha7 subtype), markedly inhibited nicotine-induced vasodilation. Nicotine-induced vasodilation was inhibited by methyllycaconitine at high concentrations (>1 microM), which non-selectively antagonize nicotinic receptors, while a low concentration of 10 nM, which selectively antagonizes alpha7 subtype, had no effect. (-)-Cytisine and (+/-)-epibatidine-induced vasodilation were abolished by mecamylamine. CONCLUSION AND IMPLICATIONS: These results suggest that the nicotinic alpha3beta4 receptor subtype, but not the alpha7 and alpha4beta2 subtypes, is responsible for the vasodilation in rat mesenteric arteries induced by nicotine- and nicotinic ACh receptor agonists through stimulation of adrenergic and CGRPergic perivascular nerves.
Authors: R J Lukas; J P Changeux; N Le Novère; E X Albuquerque; D J Balfour; D K Berg; D Bertrand; V A Chiappinelli; P B Clarke; A C Collins; J A Dani; S R Grady; K J Kellar; J M Lindstrom; M J Marks; M Quik; P W Taylor; S Wonnacott Journal: Pharmacol Rev Date: 1999-06 Impact factor: 25.468
Authors: J M Lundberg; L Terenius; T Hökfelt; C R Martling; K Tatemoto; V Mutt; J Polak; S Bloom; M Goldstein Journal: Acta Physiol Scand Date: 1982-12
Authors: Mahmoud M el-Mas; Sahar M el-Gowilly; Eman Y Gohar; Abdel-Rheem M Ghazal; Abdel A Abdel-Rahman Journal: Life Sci Date: 2010-11-16 Impact factor: 5.037
Authors: Eman Y Gohar; Sahar M El-gowilly; Hanan M El-Gowelli; Maha A El-Demellawy; Mahmoud M El-Mas Journal: PLoS One Date: 2014-04-14 Impact factor: 3.240